Exacerbations and time spent outdoors in chronic obstructive pulmonary disease.
暂无分享,去创建一个
John R Hurst | J. Wedzicha | G. Donaldson | J. Hurst | T. Wilkinson | Jadwiga A Wedzicha | Gavin C Donaldson | Tom M A Wilkinson | Wayomi R Perera | W. Perera
[1] P M Calverley,et al. Health status deterioration in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[2] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[3] E. Wouters,et al. Chronic obstructive pulmonary disease • 5: Systemic effects of COPD , 2002, Thorax.
[4] P. Jones,et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. , 1998, The European respiratory journal.
[5] R. Stockley,et al. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. , 2001, American journal of respiratory and critical care medicine.
[6] J. Garcia-Aymerich,et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study , 2003, Thorax.
[7] T. Murphy,et al. Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.
[8] A. Ionescu,et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[9] Catherine Pettinari,et al. The last year of life of COPD: a qualitative study of symptoms and services. , 2004, Respiratory medicine.
[10] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[11] L. Edwards. Modern statistical techniques for the analysis of longitudinal data in biomedical research , 2000, Pediatric pulmonology.
[12] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[13] I. Grant,et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. , 1982, Archives of internal medicine.
[14] E. Bozkanat,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.
[15] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[16] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[17] A J Block,et al. Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. , 1973, Chest.
[18] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[19] T. Seemungal,et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[20] P. Casán,et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. , 2002, American journal of respiratory and critical care medicine.
[21] P. Jones,et al. Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. , 1997, The European respiratory journal.
[22] C. Roberts,et al. Arterialised earlobe blood gas analysis: an underused technique. , 1994, Thorax.
[23] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[24] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[25] T. Seemungal,et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease , 2000, The European respiratory journal.
[26] R. Rogers,et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.
[27] M. Decramer,et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003, Thorax.
[28] T. Seemungal,et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[29] T. Seemungal,et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.
[30] T. Seemungal,et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[31] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[32] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[33] J. Wedzicha,et al. Assessment and follow up of patients prescribed long term oxygen treatment. , 1993, Thorax.
[34] M. Decramer,et al. Systemic effects of COPD. , 2005, Respiratory medicine.